Welcome to our dedicated page for Infleqtion SEC filings (Ticker: INFQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Infleqtion's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Infleqtion's regulatory disclosures and financial reporting.
Infleqtion, Inc. amended a Schedule 13G/A to report ownership details for certain reporting persons. The filing shows Tyler Brous beneficially owned 1,407,392 shares, representing 0.7% of common stock. The reporting persons state they ceased to be beneficial owners of more than 5% on April 23, 2026 and are no longer required to file under the higher reporting threshold.
Infleqtion, Inc. amended a Schedule 13G/A to report ownership details for certain reporting persons. The filing shows Tyler Brous beneficially owned 1,407,392 shares, representing 0.7% of common stock. The reporting persons state they ceased to be beneficial owners of more than 5% on April 23, 2026 and are no longer required to file under the higher reporting threshold.
Infleqtion, Inc. insider filings show a major restructuring by LCP Quantum investment funds associated with manager Tyler Brous. On April 23, 2026, these funds completed “other” transactions that together reclassified and distributed 30,528,914 shares of Common Stock to their own investors, pro rata and without consideration.
Because the funds distributed the shares they had held directly, the reporting persons are no longer deemed 10% owners and are no longer subject to Section 16(a) for Infleqtion securities. A related entry on April 22, 2026 shows Tyler Brous holding 1,403,922 Common shares directly after a change in the form of beneficial ownership from indirect to direct under Rule 16a-13.
Infleqtion, Inc. insider filings show a major restructuring by LCP Quantum investment funds associated with manager Tyler Brous. On April 23, 2026, these funds completed “other” transactions that together reclassified and distributed 30,528,914 shares of Common Stock to their own investors, pro rata and without consideration.
Because the funds distributed the shares they had held directly, the reporting persons are no longer deemed 10% owners and are no longer subject to Section 16(a) for Infleqtion securities. A related entry on April 22, 2026 shows Tyler Brous holding 1,403,922 Common shares directly after a change in the form of beneficial ownership from indirect to direct under Rule 16a-13.
Infleqtion, Inc. reported that director David B. Singer was granted stock options covering 33,928 shares of common stock at an exercise price of $12.59 per share. The options vest in full on the earlier of May 23, 2027 or the issuer's next annual stockholder meeting after April 10, 2026, subject to his continuous service. These options expire on April 10, 2036. According to the disclosure, the economic benefit of this director compensation passes to Maverick Ventures Investment Fund, L.P. through a management fee offset, and Singer disclaims beneficial ownership except to the extent of his pecuniary interest.
Infleqtion, Inc. reported that director David B. Singer was granted stock options covering 33,928 shares of common stock at an exercise price of $12.59 per share. The options vest in full on the earlier of May 23, 2027 or the issuer's next annual stockholder meeting after April 10, 2026, subject to his continuous service. These options expire on April 10, 2036. According to the disclosure, the economic benefit of this director compensation passes to Maverick Ventures Investment Fund, L.P. through a management fee offset, and Singer disclaims beneficial ownership except to the extent of his pecuniary interest.
Infleqtion, Inc. reported that director David B. Singer received a grant of stock options covering 33,928 shares of common stock at an exercise price of $12.59 per share. The options were awarded at no cost and expire on April 10, 2036.
The options vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting following April 10, 2026, subject to Mr. Singer’s continued board service. After this grant, 33,928 derivative securities of this type are reported as beneficially owned indirectly.
Infleqtion, Inc. reported that director David B. Singer received a grant of stock options covering 33,928 shares of common stock at an exercise price of $12.59 per share. The options were awarded at no cost and expire on April 10, 2036.
The options vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting following April 10, 2026, subject to Mr. Singer’s continued board service. After this grant, 33,928 derivative securities of this type are reported as beneficially owned indirectly.
Infleqtion, Inc. director David B. Singer received a grant of stock options covering 33,928 shares of common stock. The options have an exercise price of $12.59 per share and expire on April 10, 2036.
These options vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting following April 10, 2026, subject to his continuous service under the company’s 2026 Equity Incentive Plan. Vesting may accelerate under the Non-Employee Director Compensation Policy.
Infleqtion, Inc. director David B. Singer received a grant of stock options covering 33,928 shares of common stock. The options have an exercise price of $12.59 per share and expire on April 10, 2036.
These options vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting following April 10, 2026, subject to his continuous service under the company’s 2026 Equity Incentive Plan. Vesting may accelerate under the Non-Employee Director Compensation Policy.
Infleqtion, Inc. director Dawn Clawson Meyerriecks received a grant of stock options as equity compensation. She was awarded 33,928 options to buy Infleqtion common stock at an exercise price of $12.59 per share, expiring on April 10, 2036. Following this grant, she holds 33,928 derivative securities linked to common stock.
The options vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting after April 10, 2026, subject to her continued service under the company’s 2026 Equity Incentive Plan and any acceleration provisions in the Non-Employee Director Compensation Policy.
Infleqtion, Inc. director Dawn Clawson Meyerriecks received a grant of stock options as equity compensation. She was awarded 33,928 options to buy Infleqtion common stock at an exercise price of $12.59 per share, expiring on April 10, 2036. Following this grant, she holds 33,928 derivative securities linked to common stock.
The options vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting after April 10, 2026, subject to her continued service under the company’s 2026 Equity Incentive Plan and any acceleration provisions in the Non-Employee Director Compensation Policy.
Infleqtion, Inc. director Kristina M. Johnson received a grant of stock options covering 22,619 shares of common stock. The options have an exercise price of $12.59 per share and expire on April 10, 2036. After this grant, she holds 22,619 derivative securities of this type.
The options vest in full on the earlier of May 23, 2027 or the company’s next annual stockholders’ meeting following April 10, 2026, subject to her continuous service under Infleqtion’s 2026 Equity Incentive Plan and its Non-Employee Director Compensation Policy.
Infleqtion, Inc. director Kristina M. Johnson received a grant of stock options covering 22,619 shares of common stock. The options have an exercise price of $12.59 per share and expire on April 10, 2036. After this grant, she holds 22,619 derivative securities of this type.
The options vest in full on the earlier of May 23, 2027 or the company’s next annual stockholders’ meeting following April 10, 2026, subject to her continuous service under Infleqtion’s 2026 Equity Incentive Plan and its Non-Employee Director Compensation Policy.
Infleqtion, Inc. director James Eric Bjornholt received a grant of stock options covering 22,619 shares of common stock. The options have an exercise price of $12.59 per share and expire on April 10, 2036. They vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting following April 10, 2026, subject to his continuous service under the company’s 2026 Equity Incentive Plan.
Infleqtion, Inc. director James Eric Bjornholt received a grant of stock options covering 22,619 shares of common stock. The options have an exercise price of $12.59 per share and expire on April 10, 2036. They vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting following April 10, 2026, subject to his continuous service under the company’s 2026 Equity Incentive Plan.
Infleqtion, Inc. director Catherine P. Lego received a grant of stock options as part of her compensation. She was awarded 22,619 options to buy Infleqtion common stock at an exercise price of $12.59 per share, expiring on April 10, 2036.
The options vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting following April 10, 2026, provided she maintains continuous service under the company’s 2026 Equity Incentive Plan. After this grant, she directly holds options for 22,619 shares.
Infleqtion, Inc. director Catherine P. Lego received a grant of stock options as part of her compensation. She was awarded 22,619 options to buy Infleqtion common stock at an exercise price of $12.59 per share, expiring on April 10, 2036.
The options vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting following April 10, 2026, provided she maintains continuous service under the company’s 2026 Equity Incentive Plan. After this grant, she directly holds options for 22,619 shares.
Infleqtion, Inc. director James Eric Bjornholt reported receiving a grant of stock options covering 29,950 shares of Common Stock on February 13, 2026. The options have an exercise price of $13.22 per share and expire on February 12, 2036.
According to the filing, one-third of the underlying shares vest on December 21, 2026, with 1/36 of the total vesting each month thereafter, subject to his continued service. This amendment also corrects a prior scrivener’s error in the originally reported first exercisable date.
Infleqtion, Inc. director James Eric Bjornholt reported receiving a grant of stock options covering 29,950 shares of Common Stock on February 13, 2026. The options have an exercise price of $13.22 per share and expire on February 12, 2036.
According to the filing, one-third of the underlying shares vest on December 21, 2026, with 1/36 of the total vesting each month thereafter, subject to his continued service. This amendment also corrects a prior scrivener’s error in the originally reported first exercisable date.